ASPECT-2 study

Lancet. 2002 Dec;360(9350):2078; author reply 2078. doi: 10.1016/S0140-6736(02)11962-3.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Coronary Disease / prevention & control*
  • Humans
  • Randomized Controlled Trials as Topic / methods*

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors